MIA2 cytokine protein modulators (Scil Protein)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMIA2 cytokine protein modulators (Scil Protein)
Drug Alias Namemelanoma inhibitory activity protein 2 (Scil Protein)
ClassificationBiologics > Protein drugs > Recombinant polypeptideDiagnostic agent (In vivo)
Mechanisms of ActionCytokines modulators
TargetsCytokines
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNavigo Proteins GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNavigo Proteins GmbH
Active IndicationsN/A
Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A